Works matching IS 21534888 AND DT 2023 AND VI 14 AND IP 6
Results: 14
Rozlytrek Now Approved for Pediatric Patients Older Than 1 Month With Solid Tumors and NTRK Gene Fusion and in New Oral Pellet Form.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 14
- Publication type:
- Article
Braftovi Plus Mektovi Now FDA Approved for Treatment of Metastatic NSCLC With BRAF Mutation.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 14
- Publication type:
- Article
Opdivo Now Approved for Adjuvant Treatment of Stage IIB/C Melanoma.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 14
- Publication type:
- Article
Tibsovo FDA Approved for Patients with Relapsed Myelodysplastic Syndromes and IDH1 Mutation.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 13
- Publication type:
- Article
Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of GEJ Adenocarcinoma.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 12
- Publication type:
- Article
Highlights From the 5th Annual Cholangiocarcinoma Summit.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 10
- By:
- Publication type:
- Article
Phase 3 Trials Show Superiority of Targeted Treatments Over Chemotherapy in Oncogene-Addicted NSCLC.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 9
- By:
- Publication type:
- Article
FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Metastatic or Recurrent Nasopharyngeal Carcinoma.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 6
- Publication type:
- Article
Fruzaqla FDA Approved for Relapsed Metastatic Colorectal Cancer.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 6
- Publication type:
- Article
Addressing Challenges to Adoption of Value-Based Agreements.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 6
- By:
- Publication type:
- Article
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 1
- By:
- Publication type:
- Article
AVBCC Keynote: The Path to Innovation in Oncology.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 1
- By:
- Publication type:
- Article
Do AI Chatbots Give Reliable Advice Regarding Cancer?
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 1
- By:
- Publication type:
- Article
Perioperative Nivolumab Extends Event-Free Survival in Resectable NSCLC.
- Published in:
- Value-Based Cancer Care, 2023, v. 14, n. 6, p. 1
- By:
- Publication type:
- Article